TCT 2023 Insights: Primary Outcomes of the Esprit BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions - The LIFE-BTK Trial
By
TCT 2023 Insights
FEATURING
Ramon Varcoe
By
TCT 2023 Insights
FEATURING
Ramon Varcoe
Comments 0
Login to view comments.
Click here to Login
